Press Releases

Oxford Performance Materials Receives FDA Clearance for 3D Printed OsteoFab® Patient-Specific Facial Device

August 19, 2014

First and Only FDA Cleared 3D Printed Polymeric Implant to Revolutionize Facial Reconstruction

Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced that it has received 510(k) clearance from the FDA for its 3D printed OsteoFab® Patient-Specific Facial Device (OPSFD).

OPM’s facial device is the first and only FDA cleared 3D printed polymeric implant for facial indications, and follows FDA clearance of the first and only 3D printed polymeric implant, OPM’s OsteoFab Patient-Specific Cranial Device, which was granted in February 2013.

Oxford Performance Materials Named “Best Global Company for 3D Healthcare Innovation” By The New Economy Magazine

August 14, 2014

OPM Honored for its Disruptive Use of Additive Manufacturing with PEKK to Print Patient-Specific Medical Prosthetics

Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, is pleased to announce that it has been named the “Best Global Company for 3D Healthcare Innovation” by The New Economy Awards. The New Economy Awards, presented by The New Economy Magazine, identify and celebrate innovative companies that are breaking new ground in the areas of technology, energy, business and strategy.

Oxford Performance Materials Announces Key Executive Appointments to Help Lead Next Chapter of Growth

August 4, 2014

Severine Zygmont Appointed President of OPM Biomedical 

Aerospace Industry Veteran, Paul Martin, Named President of OPM Aerospace & Industrial

SOUTH WINDSOR, Conn., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced the appointment of Severine Zygmont and Paul Martin as Presidents of OPM Biomedical and OPM Aerospace & Industrial divisions, respectively.

Oxford Performance Materials Opens New South Windsor Facility to Support 3D Printing of Aerospace Components

September 9, 2013

- New facility to support Mission Critical OXPEKK® aerospace production

Oxford Performance Materials (OPM) is pleased to announce the creation of a new manufacturing facility in South Windsor, CT. The facility is in close proximity to OPM’s current headquarters and manufacturing facility. This region of Connecticut, long known for its advanced subtractive manufacturing technologies, is now rapidly becoming a global leader in additive manufacturing. "It has always been our intention to pivot from biomedical 3D printing to Mission Critical aerospace and industrial structures," said Scott DeFelice, President and CEO of OPM. “This new facility will bring together world class technologies and capabilities in order to service the exacting demands of our customers in the fast evolving 3D printing marketplace."

OPM Receives Contract from Northrop Grumman Corporation to Enable Usage of 3D-Printed Parts

July 29, 2013

– Contract award initiated by NAMII further enhances the firm’s position in mission-critical additive manufacturing

Oxford Performance Materials (OPM) is very pleased to announce that it has received a contract from Northrop Grumman Systems Corporation (NGSC) for the development of its OXPEKK® polymer for use in aerospace applications. OPM shall undertake the production of test specimens and prototype components that will allow for the establishment of a structural design database. Such a database is a necessary requirement for the design of aerospace and other critical structures.

Oxford Performance Materials and Biomet Microfixation Join Forces

April 8, 2013

– Biomet Microfixation signs agreement for exclusive distribution of OPM’s OsteoFab™ cranial implants

Oxford Performance Materials (OPM) and Biomet Microfixation (Biomet) have entered into an exclusive distribution agreement for OPM’s OsteoFab™ Patient Specific Cranial Device (OPSCD).  Under the terms of the agreement, Biomet will have exclusive global distribution rights to the OPSCD and OsteoFab™ implants for craniomaxillofacial (CMF).

OsteoFab™ Patient Specific Cranial Device Receives 510(k) Approval - OsteoFab™ Implants Ready for US Market and Beyond

February 18, 2013

Oxford Performance Materials (OPM) is pleased to announce it has received FDA 510(k) clearance Implant made with OPM's OsteoFab Technologyfor the OsteoFab™ Patient Specific Cranial Device (OPSCD). “OsteoFab” is OPM’s brand for Additively Manufactured medical and implant parts produced from PEKK polymer. With OPM’s Additive Manufacturing process (also called “3D Printing”), implants are “grown” layer by layer directly from a digital CAD file without the aid of tooling and with few practical limits on what can be produced. As such, the OsteoFab™ technology is ideal for one-of implants specifically shaped to each patient’s anatomy. One very desirable use of patient specific implants and the indication for the OPSCD is cranial implants to replace bony voids in the skull due to trauma or disease. FDA clearance of this device marks the first approval for an additively manufactured polymer implant.

Oxford Performance Materials to Participate in the National Additive Manufacturing Innovation Institute (NAMII)

August 22, 2012

Additive Manufacturing with OXPEKKOxford Performance Materials (South Windsor, CT) has been selected as part of a team to participate in the National Additive Manufacturing Innovation Institute (NAMII).  NAMII is the pilot institute for the National Network for Manufacturing Innovation (NNMI), the initiative announced by President Obama in March 2012.  OPM will work as part of a larger team of universities, companies, and organizations led by the National Center for DeFense Manufacturing and Machining (NCDMM). A collaborative inter-agency team determined that Additive Manufacturing, specifically, would garnish the most benefit for the nation’s defense, energy, space and commercial sectors.

OPM Acquires Optical Inspection Technology Rights from the Connecticut Center for Advanced Technology

July 30, 2012

Oxford Performance Materials (OPM) has acquired the rights to modify and advance the Structured Light Scanning (SLS) system developed by Connecticut Center for Advanced Technology, Inc. (CCAT). The technology was designed  by CCAT under a U.S. Air Force research contract  to produce 100% optical measurement of highly complex, light-weight, efficient structures. 

OPM is at the forefront of creating such complex structures via additive manufacturing in both biomedical and industrial markets.  The opportunity to enhance a technology and further customize it to the needs of a rapidly emerging technology like additive manufacturing will allow for greater adoption of Structured Light Scanning and will propel the wide-spread use of additive manufacturing.

OPM Announces Patient-Specific Implants

December 9, 2011
by Biloine W. Young in the Orthopedics This Week

OsteoFab, a division of Oxford Performance Materials (OPM) of South Windsor, Connecticut has manufactured and shipped its first patient-specific implant.  According to OPM President Scott DeFelice, the custom-designed implant is made by a selective laser sintering machine from a polymer called polyetherketoneketone or PEKK.

Spinal Cages Made from OXPEKK®-IG Receive Regulatory Approvals in Argentina and Peru

November 29, 2011

Oxford Performance Materials is pleased to announce that an innovative spinal device made from OXPEKK®-IG has recently received regulatory approvals in two South American countries.  Following great success in Europe, the FILL-SQUALE™ cervical cage has been approved for long-term implantation by ANMAT and DIGEMID, the regulatory authorities in Argentina and Peru, respectively.

OPM Secures $1.2M in Funding for Purchase of EOSINT P 800 SLS Machine

July 5, 2011

OPM is very pleased to announce it has secured funding for the purchase of an EOSINT P 800 SLS machine for the production of the firm's OsteoFab™ medical implants. The funding was provided by the Connecticut Innovations, Inc.'s BioScience Facilities Fund.

Oxford Performance Materials Opens New European Office

June 21, 2011

Oxford Performance Materials is pleased to announce the recent opening of a new European office in the Netherlands. The firm has long had a strong customer base in Europe, most notably in France and Germany, a base that continues to grow as OPM introduces new technologies to their OXPEKK® product line.

Oxford Performance Material Purchases PEKK Medical Business from Arkema

June 6, 2011

The founders of Oxford Performance Materials, Inc. (OPM) have acquired the PEKK medical business from Arkema, Inc. From the founding of OPM in 2000 the firm has nurtured both industrial and medical business activities. Since the acquisition of Arkema in 2009 both business units have grown rapidly.

Device made with OXPEKK®-IG Polymer Receives ANVISA Approval

September 8, 2010

-Brazilian Market Growth Anticipated for OXPEKK-IG, OPM’s branded PEKK

Oxford Performance Materials (OPM) is pleased to announce that a medical device produced with its OXPEKK®-IG polymer has received ANVISA clearance. ANVISA is the regulatory authority for the Brazilian market. The approved device is produced by Sintea Plustek and is a long-term spinal implant. This regulatory clearance now establishes a path forward for OPM to sell its products in the highly dynamic Brazilian market.

Device Manufactured with OXPEKK®-IG Polymer Receives US FDA Regulatory Clearance

July 15, 2010

-US Market Focus Accelerating for OXPEKK®-IG, OPM's branded PEKK

Oxford Performance Materials (OPM) is pleased to announce that a long-term implantable medical device manufactured with its OXPEKK®-IG polymer has received 510(k) Clearance by the United States Food and Drug Administration (FDA). The device is produced by Kent Medical Devices (KMD) from OPM’s radio-opaque OXPEKK®-IG polymer containing barium sulfate. This regulatory clearance now establishes a path forward for OPM to sell its products in the highly desirable US market. 

OXPEKK-IG Device Viking gains Regulatory Approval in Korea

July 8, 2010

-KFDA Acceptance of OXPEKK-IG Implantable Polymer

Oxford Performance Materials (OPM) is very pleased to announce that the firm’s OXPEKK-IG long-term implantable polymer has been accepted by the Korean Food and Drug Administration (KFDA). The KFDA approved the Viking interspinous spinal device made by OPM’s customer Sintea Plustek.